J Korean Ophthalmol Soc.  2000 Oct;41(10):2241-2246.

Association of HLA Type with Stevens-Johnson Syndrome Induced by Methazolamide Treatment

Affiliations
  • 1Department of Ophthalmology, St.Mary's Hospital, College of Medicine, The Catholic University of Korea, #62, Yoido-dong, Youngdeungpo-ku, Seoul, 150-713, Korea.
  • 2Department of Ophthalmology, Kangnam St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

There have been reports between Stevens-Johnson syndrome (SJS)induced by methazolamide treatment and genetic background especially in Japanese and Korean descent.We report 6 cases of SJS and the results of HLA (human leukocyte antigen)typing that suggest a relationship between genetic background and SJS induced by methazolamide treatment. We observed 6 patients as the subjects of this research, who had been suffering from SJS induced by methazolamide treatment at the Department of Ophthalmology, Catholic University.SJS appeared about 2 weeks after the patient started taking methazolamide (100 or 200 mg/d).After 15~30 days of treatment, they recovered with no serious complication.The results of HLA typing carried out 6 patients that all of the patients had HLA-A2, 5 patients were HLA-Cw1 and HLA-B59. Methazolamide should be carefully prescribed in patients of Japanese or Koreans descent and should not prescribe sulfonamide in SJS patients. A further systematic research on more cases is required to explaining ethnic peculiarity of the syndrome.

Keyword

Stevens-Johnson syndrome; Methazolamide; HLA typing

MeSH Terms

Asian Continental Ancestry Group
Histocompatibility Testing
HLA-A2 Antigen
Humans
Leukocytes
Methazolamide*
Ophthalmology
Stevens-Johnson Syndrome*
HLA-A2 Antigen
Methazolamide
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr